Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 121.77 Million | 108.9 Million | 147.06 Million | 206.62 Million | 297.07 Million | 358.47 Million |
| Cost of Revenue | 98.36 Million | 83.92 Million | 101.14 Million | 126.44 Million | 149.6 Million | 221.69 Million |
| Gross Profit | 23.41 Million | 24.97 Million | 45.92 Million | 80.17 Million | 147.46 Million | 136.77 Million |
| Operating Expenses | 64.1 Million | 53.4 Million | 64.2 Million | 85.18 Million | 156.26 Million | 127.51 Million |
| Selling, General and Administrative Expenses | 16.21 Million | 18.24 Million | 37.14 Million | 64.15 Million | 121.57 Million | 86.49 Million |
| Research and Development Expenses | 482.21 Thousand | 1.58 Million | 1.33 Million | 642.88 Thousand | 4.77 Million | 7.57 Million |
| Other Expenses | 44.28 Million | 33.58 Million | 25.72 Million | 20.38 Million | 29.91 Million | 12.18 Million |
| Cost and Expenses | 159.34 Million | 137.33 Million | 165.35 Million | 211.63 Million | 305.87 Million | 349.21 Million |
| Operating Income | -37.56 Million | -28.43 Million | -18.28 Million | 989.72 Thousand | -252.03 Thousand | -3.91 Million |
| Interest Expense | 7.24 Million | 7.4 Million | 7.35 Million | 6.92 Million | 6.22 Million | 8.88 Million |
| Income Tax Expense | 2.98 Million | 842.17 Thousand | -953.6 Thousand | 935.43 Thousand | 1.4 Million | 6.06 Million |
| Earnings before Tax | -36.31 Million | -72.36 Million | -33.73 Million | -50.61 Million | 53.46 Million | -595.99 Thousand |
| Net Income | -38.27 Million | -73.2 Million | -32.78 Million | -51.54 Million | 50.68 Million | -9.87 Million |
| Earnings Per Share Basic | -0.31 | -0.60 | -0.27 | -0.42 | 0.42 | -0.08 |
| Earnings Per Share Diluted | -0.31 | -0.60 | -0.27 | -0.42 | 0.42 | -0.08 |
| Weighted Average Shares Outstanding | 121.77 Million | 121.77 Million | 121.77 Million | 121.77 Million | 121.77 Million | 121.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 121.77 Million | 121.77 Million | 121.77 Million | 121.77 Million | 121.77 Million | 123.45 Million |
| Gross Margin | 0.19 | 0.23 | 0.31 | 0.39 | 0.50 | 0.38 |
| EBIT Margin | -0.12 | -0.11 | -0.01 | 0.05 | 0.04 | 0.07 |
| Profit Margin | -0.31 | -0.67 | -0.22 | -0.25 | 0.17 | -0.03 |
| EBITDA | -14.11 Million | -44.11 Million | -14.07 Million | -32.75 Million | 73.34 Million | 21.61 Million |
| Earnings Before Tax Margin | -0.31 | -0.26 | -0.12 | 0.00 | -0.00 | -0.01 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 64.56 Million | 31.81 Million | 38.33 Million | 121.77 Million | 35.67 Million | 35.15 Million |
| Cost of Revenue | 27.9 Million | 24.16 Million | 29.89 Million | 95.24 Million | 28.75 Million | 27.04 Million |
| Gross Profit | 36.65 Million | 7.65 Million | 8.43 Million | 26.53 Million | 6.91 Million | 8.11 Million |
| Operating Expenses | 18.34 Million | 18.5 Million | 18.08 Million | 48.41 Million | 13.82 Million | 10.75 Million |
| Selling, General and Administrative Expenses | 18.34 Million | -4.03 Million | 18.13 Million | - | -17.82 Million | 24.98 Million |
| Research and Development Expenses | - | 106.79 Thousand | - | - | 39.26 Thousand | 441.58 Thousand |
| Other Expenses | - | 2.22 Million | 843.51 Thousand | 1.25 Million | 6.06 Million | -5.15 Million |
| Cost and Expenses | 46.24 Million | 42.66 Million | 47.98 Million | 143.66 Million | 42.58 Million | 37.79 Million |
| Operating Income | 18.31 Million | -13.53 Million | -10.91 Million | -37.56 Million | -14.84 Million | -2.03 Million |
| Interest Expense | 1.07 Million | 2.66 Million | 1.55 Million | 7.18 Million | 2.5 Million | 1.35 Million |
| Income Tax Expense | 2.62 Million | -2.52 Million | 25.78 Thousand | 2.98 Million | 2.98 Million | 153.95 Thousand |
| Earnings before Tax | 17.75 Million | -11.3 Million | -10.07 Million | -36.31 Million | -8.78 Million | -3.88 Million |
| Net Income | 14.8 Million | -8.77 Million | -9.72 Million | -38.27 Million | -10.81 Million | -4.03 Million |
| Earnings Per Share Basic | 0.12 | -0.07 | -0.08 | - | -0.09 | -0.03 |
| Earnings Per Share Diluted | 0.12 | -0.07 | -0.08 | - | -0.09 | -0.03 |
| Weighted Average Shares Outstanding | 121.77 Million | 121.83 Million | 121.83 Million | 121.77 Million | 121.82 Million | 121.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 121.77 Million | 121.83 Million | 121.83 Million | 121.77 Million | 121.82 Million | 121.77 Million |
| Gross Margin | 0.57 | 0.24 | 0.22 | 0.22 | 0.19 | 0.23 |
| EBIT Margin | 0.29 | -0.28 | -0.23 | - | -0.01 | -0.15 |
| Profit Margin | 0.23 | -0.28 | -0.25 | -0.31 | -0.30 | -0.11 |
| EBITDA | 18.82 Million | -8.75 Million | -8.68 Million | - | -508.58 Thousand | -5.31 Million |
| Earnings Before Tax Margin | 0.28 | -0.43 | -0.28 | -0.31 | -0.42 | -0.06 |
KSIOF
3497
0KU1
5902
6737
GFL